Company to Discuss Upcoming Phase 1/2 Study of Twice Per Year Treatment for AMD
Continue ReadingTag: graybug-vision
Graybug Vision–s Potential Once-Per-Year AMD Treatment Data Presented at ARVO 2017
Company Developing Injectable Products for Treating Glaucoma and AMD
Continue ReadingValerie Smith Joins Graybug Vision as VP, Global Clinical Development Operations
REDWOOD CITY, CA — (Marketwired) — 05/08/17 — Graybug Vision, Inc., a venture-stage pharmaceutical company committed…
Continue ReadingGraybug Vision to Present at the 16th Annual Needham Healthcare Conference on April 4
REDWOOD CITY, CA -- (Marketwired) -- 04/04/17 -- Graybug Vision, Inc., a venture-stage pharmaceutical company committed…
Continue ReadingGraybug Vision CEO Jeffrey Cleland Discusses Company–s Prodrug Technology at Glaucoma 360 on February 3
Novel Glaucoma Compounds May Provide Long-Acting Treatment Duration
Continue ReadingGraybug Vision Appoints Thomas S. Templeman, PhD, as Chief Operating Officer
REDWOOD CITY, CA -- (Marketwired) -- 01/03/17 -- Graybug Vision, Inc., a venture-stage pharmaceutical company committed…
Continue Reading